Index RUT
P/E 46.90
EPS (ttm) 1.74
Insider Own 2.49%
Shs Outstand 57.86M
Perf Week -0.70%
Market Cap 4.75B
Forward P/E 22.48
EPS next Y 3.64
Insider Trans -5.12%
Shs Float 56.66M
Perf Month -2.33%
Income 101.95M
PEG 4.36
EPS next Q 0.88
Inst Own 102.17%
Short Float 4.43%
Perf Quarter 13.83%
Sales 1.28B
P/S 3.71
EPS this Y 10.71%
Inst Trans 1.98%
Short Ratio 7.20
Perf Half Y 13.74%
Book/sh 21.35
P/B 3.83
EPS next Y 9.20%
ROA 5.08%
Short Interest 2.51M
Perf Year -1.37%
Cash/sh 10.05
P/C 8.14
EPS next 5Y 10.77%
ROE 8.45%
52W Range 62.58 - 85.18
Perf YTD 7.69%
Dividend Est. -
P/FCF 35.57
EPS past 5Y 15.74%
ROI 4.85%
52W High -3.97%
Beta 0.87
Dividend TTM -
Quick Ratio 4.38
Sales past 5Y 7.42%
Gross Margin 42.94%
52W Low 30.71%
ATR (14) 1.43
Dividend Ex-Date -
Current Ratio 6.03
EPS Y/Y TTM 18.90%
Oper. Margin 10.88%
RSI (14) 53.02
Volatility 1.80% 1.58%
Employees 6950
Debt/Eq 0.70
Sales Y/Y TTM 9.62%
Profit Margin 7.96%
Recom 1.64
Target Price 92.24
Option/Short Yes / Yes
LT Debt/Eq 0.69
EPS Q/Q 35.53%
Payout 0.00%
Rel Volume 0.72
Prev Close 82.73
Sales Surprise 2.52%
EPS Surprise 7.78%
Sales Q/Q 9.07%
Earnings Apr 30 AMC
Avg Volume 348.81K
Price 81.80
SMA20 -0.45%
SMA50 4.66%
SMA200 10.73%
Trades
Volume 251,988
Change -1.12%
Date
Action
Analyst
Rating Change
Price Target Change
Apr-11-24 Initiated
CL King
Buy
$88
Feb-07-24 Initiated
BofA Securities
Neutral
$87
Dec-21-23 Upgrade
Canaccord Genuity
Hold → Buy
$100
Dec-20-22 Downgrade
Canaccord Genuity
Buy → Hold
$73 → $72
Jan-05-21 Upgrade
Needham
Hold → Buy
$65
Sep-28-20 Upgrade
Wells Fargo
Underweight → Equal Weight
$42
Feb-25-20 Downgrade
Barrington Research
Outperform → Mkt Perform
Feb-03-20 Upgrade
Raymond James
Mkt Perform → Outperform
$43
Dec-12-19 Downgrade
Wells Fargo
Market Perform → Underperform
$26
Sep-24-19 Initiated
Oppenheimer
Outperform
Sep-10-19 Downgrade
Raymond James
Outperform → Mkt Perform
Jul-26-19 Downgrade
Wells Fargo
Outperform → Market Perform
Jul-26-19 Downgrade
Needham
Buy → Hold
Oct-02-18 Reiterated
Needham
Buy
$67 → $73
Aug-07-18 Downgrade
BofA/Merrill
Buy → Underperform
Jul-24-18 Reiterated
Needham
Buy
$54 → $67
Jun-01-18 Reiterated
Needham
Buy
$54
May-18-18 Reiterated
SunTrust
Buy
$55 → $62
Apr-26-18 Reiterated
Needham
Buy
$53 → $54
Apr-20-18 Initiated
Needham
Buy
$53
Show Previous Ratings
Jun-11-24 09:50AM
Jun-07-24 09:45AM
May-30-24 11:31AM
May-23-24 09:50AM
May-22-24 12:23PM
12:21PM
Loading…
12:21PM
May-21-24 09:25AM
May-16-24 04:05PM
May-15-24 04:52PM
04:05PM
12:11PM
May-14-24 11:58AM
09:25AM
May-01-24 12:47PM
11:27AM
10:47AM
Loading…
10:47AM
(Thomson Reuters StreetEvents)
09:15AM
03:32AM
Apr-30-24 09:55PM
06:30PM
05:38PM
05:30PM
04:38PM
(Associated Press Finance)
04:05PM
Apr-23-24 10:01AM
Apr-10-24 09:33AM
Mar-29-24 11:30AM
Mar-27-24 09:40AM
Mar-20-24 11:28AM
Mar-19-24 09:25AM
05:19PM
Loading…
Mar-18-24 05:19PM
Mar-08-24 05:00PM
09:40AM
Mar-07-24 10:43AM
Mar-05-24 09:25AM
Mar-01-24 04:32AM
Feb-29-24 11:24AM
11:03AM
07:38AM
(Thomson Reuters StreetEvents)
Feb-28-24 07:00PM
06:15PM
05:21PM
(Associated Press Finance)
04:05PM
04:05PM
Feb-23-24 09:15AM
Feb-21-24 10:00AM
Feb-19-24 08:38AM
Feb-15-24 09:25AM
Jan-31-24 12:10PM
09:50AM
Jan-30-24 09:55AM
Jan-24-24 01:01PM
Jan-23-24 07:19AM
Jan-16-24 04:05PM
Jan-08-24 09:00AM
Jan-03-24 04:05PM
Dec-27-23 05:11AM
Dec-18-23 04:05PM
Dec-15-23 09:50AM
Dec-11-23 10:25AM
Dec-06-23 09:00AM
Dec-04-23 04:05PM
Nov-15-23 07:28AM
Nov-01-23 09:55AM
Oct-31-23 11:40AM
Oct-30-23 01:37AM
Oct-27-23 12:20PM
11:16AM
10:51AM
(Thomson Reuters StreetEvents)
Oct-26-23 07:30PM
05:50PM
05:48PM
04:40PM
(Associated Press Finance)
04:05PM
07:52AM
Oct-25-23 10:21AM
Oct-12-23 11:55AM
Oct-10-23 11:40AM
09:25AM
Oct-05-23 11:05AM
09:25AM
Sep-19-23 09:00AM
Sep-07-23 07:22AM
Sep-06-23 09:25AM
Aug-30-23 12:46PM
Aug-15-23 01:20PM
Aug-10-23 07:58AM
Aug-08-23 06:50AM
Aug-03-23 09:25AM
Jul-26-23 12:07PM
Jul-25-23 08:00PM
05:45PM
04:43PM
04:05PM
Jul-21-23 06:51AM
Jul-13-23 11:56AM
Jul-11-23 11:40AM
Jul-07-23 07:20AM
Jul-06-23 01:11PM
Jul-03-23 07:51AM
Merit Medical Systems, Inc. engages in the manufacture and marketing of proprietary disposable medical devices. It operates through the Cardiovascular and Endoscopy segments. The Cardiovascular segment consists of peripheral intervention, cardiac intervention, interventional oncology and spine, and cardiovascular and critical care product groups. The Endoscopy segment integrates non-vascular stent technology with balloon dilators, inflation devices, guide wires, procedure kits, and other devices that are used by gastroenterologists, endoscopists, pulmonologists, and thoracic and general surgeons. The company was founded by Fred P. Lampropoulos, Darla Gill, Kent W. Stanger, and William Padilla in July 1987 and is headquartered in South Jordan, UT.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Peterson Neil CHIEF OPERATING OFFICER Jun 10 '24 Option Exercise 44.80 7,500 336,000 22,319 Jun 12 01:28 PM Peterson Neil CHIEF OPERATING OFFICER Jun 10 '24 Sale 81.85 7,500 613,845 14,819 Jun 12 01:28 PM Parra Raul Jr. CFO AND TREASURER Mar 12 '24 Sale 73.95 6,480 479,182 12,007 Mar 13 06:36 PM Wright Joseph CHIEF COMMERCIAL OFFICER Mar 07 '24 Option Exercise 28.20 25,000 705,000 67,223 Mar 08 03:40 PM Wright Joseph CHIEF COMMERCIAL OFFICER Mar 07 '24 Sale 75.68 25,000 1,891,925 42,223 Mar 08 03:40 PM Peterson Neil CHIEF OPERATING OFFICER Mar 06 '24 Option Exercise 44.80 7,500 336,000 14,819 Mar 08 10:11 AM Gunderson Thomas James Director Mar 04 '24 Option Exercise 34.40 25,000 860,000 37,414 Mar 05 12:13 PM Gunderson Thomas James Director Mar 04 '24 Sale 76.03 18,157 1,380,513 19,257 Mar 05 12:13 PM Evans Stephen C. Director Mar 04 '24 Sale 76.35 1,000 76,348 7,226 Mar 05 10:13 AM Millner F. Ann Director Jan 22 '24 Option Exercise 34.40 20,000 688,000 49,960 Jan 24 10:49 AM Millner F. Ann Director Jan 22 '24 Sale 80.00 20,000 1,600,000 29,960 Jan 24 10:49 AM LAMPROPOULOS FRED P PRESIDENT AND CEO Aug 25 '23 Option Exercise 28.20 200,000 5,640,000 1,167,916 Aug 29 06:08 PM LAMPROPOULOS FRED P PRESIDENT AND CEO Aug 25 '23 Option Exercise 28.20 6,000 169,200 12,888 Aug 29 06:08 PM Peterson Neil CHIEF OPERATING OFFICER Aug 22 '23 Option Exercise 28.20 8,000 225,600 8,000 Aug 23 11:32 AM Peterson Neil CHIEF OPERATING OFFICER Aug 22 '23 Sale 67.91 8,000 543,288 0 Aug 23 11:32 AM ANDERSON A SCOTT Director Aug 09 '23 Option Exercise 50.50 25,000 1,262,500 71,397 Aug 11 05:30 PM ANDERSON A SCOTT Director Aug 09 '23 Sale 69.40 22,180 1,539,292 49,217 Aug 11 05:30 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite